Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company - Announces grant of a patent for Alkindi by the European Patent Office. The patent provides in-market European protection until 2032 in all designated states of the European Patent Convention.
Current stock price: 52.00 pence
Year-to-date change: up 80%
By Arvind Bhunjun; arvindbhunjun@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.